| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026530793 |
| P356 | DOI | 10.1038/NG1294-345 |
| P3181 | OpenCitations bibliographic resource ID | 1964082 |
| P698 | PubMed publication ID | 7894484 |
| P5875 | ResearchGate publication ID | 260198915 |
| P50 | author | Douglas A Marchuk | Q93131481 |
| P2093 | author name string | M A Baldwin | |
| D W Johnson | |||
| K A McAllister | |||
| C E Jackson | |||
| D S Markel | |||
| E A Helmbold | |||
| W C McKinnon | |||
| J Murrell | |||
| C J Gallione | |||
| K M Grogg | |||
| P2860 | cites work | COL5A1: fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II | Q72258875 |
| A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34 | Q72372682 | ||
| A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3 | Q72372689 | ||
| The TGF-beta family and its composite receptors | Q75293083 | ||
| Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen | Q24304358 | ||
| Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions | Q24313124 | ||
| Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells | Q24315277 | ||
| TGF beta signals through a heteromeric protein kinase receptor complex | Q24337608 | ||
| Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 | ||
| Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts | Q28186129 | ||
| Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
| Mechanism of activation of the TGF-beta receptor | Q28245861 | ||
| Assignment of the human endoglin gene (END) to 9q34-->qter | Q28264211 | ||
| Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system | Q28304498 | ||
| Expression cloning and characterization of the TGF-beta type III receptor | Q28304515 | ||
| Maternal rescue of transforming growth factor-beta 1 null mice | Q28511932 | ||
| Genetic heterogeneity in hereditary haemorrhagic telangiectasia | Q33596273 | ||
| Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype | Q33596279 | ||
| Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity | Q33596285 | ||
| Integrins as dynamic regulators of vascular function | Q40392606 | ||
| Betaglycan presents ligand to the TGF beta signaling receptor. | Q41542611 | ||
| Report and abstracts of the Third International Workshop on Chromosome 9. Cambridge, United Kingdom, 9-11 April, 1994. | Q42489729 | ||
| Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells | Q46232948 | ||
| Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. | Q46789725 | ||
| Hereditary hemorrhagic telangiectasia. An electron microscopic study. | Q54131915 | ||
| Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia | Q68558666 | ||
| PCR buffer optimization with uniform temperature regimen to facilitate automation | Q70586071 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| endoglin | Q3054016 | ||
| central nervous system vasculogenesis | Q14902762 | ||
| P304 | page(s) | 345-51 | |
| P577 | publication date | 1994-12-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 | |
| P478 | volume | 8 |
| Q35750778 | 5'UTR mutations of ENG cause hereditary hemorrhagic telangiectasia. |
| Q54657320 | A DNA sequence polymorphism in the endoglin gene is not associated with intracranial aneurysm or aneurysmal subarachnoid hemorrhage. |
| Q84633772 | A Revised Concept of the Congenital Nature of Cerebral Arteriovenous Malformations |
| Q34999903 | A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab |
| Q58789117 | A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations |
| Q34306976 | A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). |
| Q24540299 | A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. |
| Q73175999 | A gene for primary pulmonary hypertension |
| Q35533971 | A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. |
| Q42364928 | A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10. |
| Q33789113 | A mouse model of heritable cerebrovascular disease |
| Q28592376 | A murine model of hereditary hemorrhagic telangiectasia |
| Q90727218 | A new ENG mutation in a Japanese family with hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations |
| Q37219463 | A novel channelopathy in pulmonary arterial hypertension |
| Q35851374 | A rare case of pulmonary arterio-venous malformation with recurrent anemia: Hereditary hemorrhagic telangiectasia |
| Q91619374 | A role for the Tgf-β/Bmp co-receptor Endoglin in the molecular oscillator that regulates the hair follicle cycle |
| Q38514602 | A spinal arteriovenous fistula in a 3-year old boy. |
| Q35127963 | ALK1 as an emerging target for antiangiogenic therapy of cancer |
| Q47856805 | ALK1 signaling in development and disease: new paradigms. |
| Q24316206 | ALK1 signaling regulates early postnatal lymphatic vessel development |
| Q30811602 | ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression |
| Q28588420 | ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 |
| Q28361871 | Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice |
| Q28510571 | Activin receptor-like kinase 1 is essential for placental vascular development in mice |
| Q24677057 | Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis |
| Q46377767 | Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation |
| Q22254570 | Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation |
| Q45781827 | Activin receptor-like kinase 5 inhibition reverses impairment of endothelial cell viability by endogenous islet mesenchymal stromal cells |
| Q37330124 | Acute paraplegia due to spinal arteriovenous fistula in two patients with hereditary hemorrhagic telangiectasia. |
| Q41684919 | Adenovirus-mediated decorin gene transfer prevents TGF-beta-induced inhibition of lung morphogenesis |
| Q37120511 | Alk1 controls arterial endothelial cell migration in lumenized vessels |
| Q50532642 | Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence. |
| Q79698921 | Alveolar exhaled nitric oxide is elevated in hereditary hemorrhagic telangiectasia |
| Q51685103 | An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts. |
| Q35776135 | An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2. |
| Q34608886 | An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia |
| Q39917647 | Analysis of uromodulin polymerization provides new insights into the mechanisms regulating ZP domain-mediated protein assembly |
| Q38086359 | Angiogenesis and hypoxia in the kidney |
| Q34606176 | Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding |
| Q34136521 | Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. |
| Q37958949 | Angiogenesis regulation by TGFβ signalling: clues from an inherited vascular disease |
| Q37847427 | Antagonism of activin by activin chimeras |
| Q41964822 | Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting |
| Q41015470 | Applications of heteroduplex analysis for mutation detection in disease genes |
| Q33210025 | Argon plasma coagulation for prevention of recurrent bleeding from GI angiodysplasias |
| Q36554606 | Arteriovenous malformations and other vascular malformation syndromes |
| Q38662338 | Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions. |
| Q37776859 | BMP signaling in vascular development and disease |
| Q41878326 | BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II. |
| Q36410172 | BMP9 regulates endoglin-dependent chemokine responses in endothelial cells |
| Q36102528 | BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration |
| Q34043809 | BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension |
| Q26824827 | BMPs and their clinical potentials |
| Q39646992 | Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors |
| Q57813960 | Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta |
| Q53167364 | Bilateral lung transplant for hereditary hemorrhagic telangiectasia in a pediatric patient. |
| Q41469668 | Biology of TGF-beta in knockout and transgenic mouse models |
| Q38040182 | Biomarkers in pre-eclampsia: a novel approach to early detection of the disease |
| Q24302790 | Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis |
| Q35335836 | Bleeding and clotting in hereditary hemorrhagic telangiectasia |
| Q35617651 | Blessing for the bleeder: bevacizumab in hereditary hemorrhagic telangiectasia |
| Q30514533 | Blood flow reprograms lymphatic vessels to blood vessels |
| Q42370494 | Bone Morphogenetic Protein 9 Enhances Lipopolysaccharide-Induced Leukocyte Recruitment to the Vascular Endothelium |
| Q57469996 | Bone Morphogenetic Protein 9 is a Mechanistic Biomarker of Portopulmonary Hypertension |
| Q37947050 | Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates |
| Q38872877 | Bone Morphogenetic Proteins in Vascular Homeostasis and Disease |
| Q24315838 | Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells |
| Q41484602 | Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2. |
| Q37340780 | Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression. |
| Q36704617 | Brain abscess as an initial presentation in a patient of hereditary haemorrhagic telangiectasia caused by a novel ENG mutation. |
| Q89216487 | Brain arteriovenous malformations |
| Q54482657 | Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations. |
| Q93067800 | Building and Regenerating the Lung Cell by Cell |
| Q37764089 | CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma |
| Q36320615 | CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells |
| Q40577523 | Cancer incidence in patients with hereditary hemorrhagic telangiectasia |
| Q42278077 | Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis |
| Q24313348 | Casein kinase 2beta as a novel enhancer of activin-like receptor-1 signaling |
| Q73847427 | Cases from the Osler Medical Service at Johns Hopkins University. Diffuse colonic angiodysplasia with chronic iron deficiency anemia |
| Q40975639 | Cell type specificity of the human endoglin promoter |
| Q35942372 | Cellular and molecular mechanisms involved in branching morphogenesis of the Drosophila tracheal system |
| Q30419393 | Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes |
| Q24314797 | Cellular response to hypoxia involves signaling via Smad proteins |
| Q35146640 | Cerebrofacial vascular disease |
| Q38855307 | ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif |
| Q91387110 | Characterization of a family mutation in the 5' untranslated region of the endoglin gene causative of hereditary hemorrhagic telangiectasia |
| Q35248963 | Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia |
| Q40439634 | Characterization of murine S-endoglin isoform and its effects on tumor development. |
| Q33619784 | Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1 |
| Q36211381 | Chronic cerebral hypoxia promotes arteriogenic remodeling events that can be identified by reduced endoglin (CD105) expression and a switch in β1 integrins |
| Q35793406 | Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice |
| Q35108385 | Circulating angiogenic cell dysfunction in patients with hereditary hemorrhagic telangiectasia |
| Q34038779 | Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia |
| Q47207494 | Clinical and genetic findings in children with central nervous system arteriovenous fistulas. |
| Q37116795 | Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia |
| Q33683412 | Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? |
| Q34006402 | Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred |
| Q42326724 | Combined juvenile polyposis and hereditary hemorrhagic telangiectasia |
| Q33678429 | Commitment and differentiation of lung cell lineages |
| Q33303941 | Computational selection and prioritization of candidate genes for fetal alcohol syndrome |
| Q34321057 | Congenital pulmonary arteriovenous malformation: a rare cause of cyanosis in childhood. |
| Q35541207 | Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling |
| Q39737133 | Contact endoscopic findings in hereditary hemorrhagic telangiectasia |
| Q27302123 | Context-specific interactions between Notch and ALK1 cannot explain ALK1-associated arteriovenous malformations |
| Q38268670 | Continuing challenges in the diagnosis and management of obscure gastrointestinal bleeding |
| Q92387633 | Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis |
| Q53420337 | Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos. |
| Q35051350 | Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1. |
| Q71230071 | Counting strokes |
| Q22252408 | Cutaneous manifestations of gastrointestinal disease |
| Q90247164 | Decreased levels of miR-28-5p and miR-361-3p and increased levels of insulin-like growth factor 1 mRNA in mononuclear cells from patients with hereditary hemorrhagic telangiectasia 1 |
| Q37363566 | Defective Connective Tissue Remodeling in Smad3 Mice Leads to Accelerated Aneurysmal Growth Through Disturbed Downstream TGF-β Signaling |
| Q30592602 | Deletion of Rbpj from postnatal endothelium leads to abnormal arteriovenous shunting in mice. |
| Q27023250 | Developmental and pathological angiogenesis in the central nervous system |
| Q37266842 | Developmental angiogenesis of the central nervous system |
| Q33802640 | Diagnosis and Treatment of Hereditary Hemorrhagic Telangiectasia |
| Q44277478 | Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. |
| Q35597702 | Diagnosis and management of pulmonary arteriovenous malformations. |
| Q33897059 | Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). |
| Q61805936 | Diagnostic yield of capsule endoscopy for small bowel arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis |
| Q39994355 | Differential gene expression patterns during embryonic development of sea urchin exposed to triclosan |
| Q36489774 | Differentiation of arterial and venous endothelial cells and vascular morphogenesis |
| Q26750721 | Diffuse Pulmonary Arteriovenous Fistulas With Pulmonary Arterial Hypertension: Case Report and Review |
| Q34784416 | Directional next-generation RNA sequencing and examination of premature termination codon mutations in endoglin/hereditary haemorrhagic telangiectasia |
| Q38233800 | Diversity is in my veins: role of bone morphogenetic protein signaling during venous morphogenesis in zebrafish illustrates the heterogeneity within endothelial cells |
| Q35787286 | Does any lower gastrointestinal bleeding in patients suffering from hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu) necessitate a full colonic visualization? |
| Q43964903 | Dynamic 4D MR angiography versus multislice CT angiography in the evaluation of vascular hepatic involvement in hereditary haemorrhagic telangiectasia. |
| Q33573626 | ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia |
| Q41896516 | ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis |
| Q37944287 | Early neonatal complications from pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: case report and review of the literature |
| Q42429387 | Ectopic Noggin in a Population of Nfatc1 Lineage Endocardial Progenitors Induces Embryonic Lethality |
| Q92007924 | Ectopic Recurrence of Arteriovenous Malformation After Radiosurgery: Case Report and Insight Regarding Pathogenesis |
| Q39326311 | Effect of endoglin overexpression during embryoid body development |
| Q26752740 | Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations |
| Q92710408 | Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial |
| Q33891975 | Embolotherapy in the bronchial and pulmonary circulations |
| Q38332401 | Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia. |
| Q58352287 | Endoglin (CD105) expression in human renal cell carcinoma |
| Q62937553 | Endoglin (CD105) expression in sinonasal polyposis |
| Q77759709 | Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity |
| Q51944540 | Endoglin (CD105) expression in the human heart throughout gestation: an immunohistochemical study. |
| Q36756322 | Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants |
| Q28207513 | Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels |
| Q43121223 | Endoglin - a marker of vascular endothelial cell proliferation in cancer |
| Q33727308 | Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading. |
| Q90194165 | Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners |
| Q30480194 | Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. |
| Q33385083 | Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH. |
| Q84718191 | Endoglin as a marker in cervical paragangliomas |
| Q61805998 | Endoglin as an Adhesion Molecule in Mature and Progenitor Endothelial Cells: A Function Beyond TGF-β |
| Q39637170 | Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome. |
| Q52126579 | Endoglin expression in early development is associated with vasculogenesis and angiogenesis. |
| Q35809742 | Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. |
| Q38074721 | Endoglin for tumor imaging and targeted cancer therapy. |
| Q44465440 | Endoglin gene mutations and polymorphisms in Italian patients with hereditary haemorrhagic telangiectasia. |
| Q34873610 | Endoglin haplo-insufficiency modifies the inflammatory response in irradiated mouse hearts without affecting structural and mircovascular changes |
| Q34119241 | Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia |
| Q33728841 | Endoglin in liver fibrogenesis: Bridging basic science and clinical practice |
| Q38364695 | Endoglin involvement in integrin-mediated cell adhesion as a putative pathogenic mechanism in hereditary hemorrhagic telangiectasia type 1 (HHT1). |
| Q64269790 | Endoglin is a conserved regulator of vasculogenesis in zebrafish - implications for hereditary haemorrhagic telangiectasia |
| Q22008597 | Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily |
| Q28510584 | Endoglin is required for myogenic differentiation potential of neural crest stem cells |
| Q36395997 | Endoglin is required in Pax3-derived cells for embryonic blood vessel formation. |
| Q36236945 | Endoglin modulates cellular responses to TGF-beta 1. |
| Q34164964 | Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis. |
| Q40251249 | Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction |
| Q27326704 | Endoglin regulates mural cell adhesion in the circulatory system |
| Q40068276 | Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer. |
| Q73409205 | Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques |
| Q41042158 | Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cells |
| Q31126839 | Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors |
| Q24291272 | Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies |
| Q89719911 | Endoglin: Beyond the Endothelium |
| Q36825271 | Endoglin: a critical mediator of cardiovascular health |
| Q34056160 | Endoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia |
| Q44117445 | Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes. |
| Q33744958 | Endothelial adhesion molecules in the development of the vascular tree: the garden of forking paths. |
| Q55332047 | Endothelial cell malignancies: new insights from the laboratory and clinic. |
| Q35181476 | Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression |
| Q33738647 | Endothelial follistatin-like-1 regulates the postnatal development of the pulmonary vasculature by modulating BMP/Smad signaling. |
| Q37671796 | Endothelial signaling and the molecular basis of arteriovenous malformation |
| Q58571918 | Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis |
| Q28487916 | Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2 |
| Q86504980 | Epidemiology of pulmonary arterial hypertension |
| Q42447535 | Epithelial tube morphogenesis during Drosophila tracheal development requires Piopio, a luminal ZP protein. |
| Q36315610 | Essential role of endothelial Smad4 in vascular remodeling and integrity. |
| Q74093216 | Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis |
| Q40958788 | Expression of normal and truncated forms of human endoglin |
| Q57849601 | Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis |
| Q36951674 | Extracellular control of TGFbeta signalling in vascular development and disease |
| Q54127845 | Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. |
| Q36226832 | Familial occurrence of brain arteriovenous malformations: a systematic review |
| Q34142690 | Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene |
| Q34076803 | Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes |
| Q35552966 | Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment |
| Q35550184 | From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family |
| Q37134125 | From germline towards somatic mutations in the pathophysiology of vascular anomalies |
| Q38948191 | Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function. |
| Q28116278 | Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia |
| Q39640769 | Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension |
| Q92476000 | Future treatments for hereditary hemorrhagic telangiectasia |
| Q42535747 | Gastric angiodysplasia in a hereditary hemorrhagic telangiectasia type 2 patient |
| Q47789552 | Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature |
| Q93929894 | Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia |
| Q33973319 | Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome |
| Q35797381 | Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease |
| Q30724640 | Gene profiling techniques and their application in angiogenesis and vascular development |
| Q38775625 | Generation and Characterization of Vascular Smooth Muscle Cell Lines Derived from a Patient with a Bicuspid Aortic Valve |
| Q37053831 | Genes and the preeclampsia syndrome |
| Q36921160 | Genetic Aspects of Cerebrovascular Malformations |
| Q90420122 | Genetic Mutation Analysis Can Supplement Clinically Confirmed Hereditary Hemorrhagic Telangiectasia Populations |
| Q60919616 | Genetic Polymorphisms Associated with Spontaneous Intracerebral Hemorrhage |
| Q37828670 | Genetic analysis of blood vessel formation role of endothelial versus smooth muscle cells |
| Q33824603 | Genetic approaches to TGFbeta signaling pathways |
| Q34510770 | Genetic aspects of pulmonary arterial hypertension |
| Q48323777 | Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan |
| Q24604623 | Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease |
| Q85121770 | Genetics and Syndromes Associated with Vascular Malformations |
| Q36752306 | Genetics and mediators in pulmonary arterial hypertension |
| Q37080526 | Genetics of pulmonary arterial hypertension |
| Q31016276 | Genetics of pulmonary arterial hypertension: recent data and practical applications |
| Q26828019 | Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility |
| Q37310665 | Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis |
| Q40051668 | Genome-wide association study of sporadic brain arteriovenous malformations |
| Q24792044 | Genomic approaches to research in pulmonary hypertension |
| Q31092753 | Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network |
| Q24795748 | Growth factor signaling in lung morphogenetic centers: automaticity, stereotypy and symmetry |
| Q36342556 | Growth factors in lung development. |
| Q36972710 | HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis. |
| Q51934035 | Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. |
| Q50998123 | Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2. |
| Q33761721 | Heart failure and pulmonary hypertension |
| Q39541994 | Hematology and oncology at the Hospital for Sick Children |
| Q35854563 | Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. |
| Q43913949 | Hepatic nodular regenerative lesions in patients with hereditary haemorrhagic telangiectasia: computed tomography and magnetic resonance findings. |
| Q50956254 | Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. |
| Q41006424 | Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease |
| Q36294968 | Hereditary Haemorrhagic Telangiectasia Cerebrospinal Localization in Adults and Children. Review of 39 cases |
| Q35680632 | Hereditary Hemorrhagic Telangiectasia with Hepatic Vascular Malformations |
| Q40205509 | Hereditary Hemorrhagic Telangiectasia: Breakpoint Characterization of a Novel Large Deletion in ACVRL1 Suggests the Causing Mechanism |
| Q41786268 | Hereditary connective tissue diseases in young adult stroke: a comprehensive synthesis |
| Q34274953 | Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) |
| Q92476058 | Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature |
| Q33691285 | Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms |
| Q33677405 | Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. |
| Q34024081 | Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment |
| Q24600839 | Hereditary haemorrhagic telangiectasia: a clinical and scientific review |
| Q40819926 | Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients |
| Q35443250 | Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations |
| Q24645017 | Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease |
| Q43169543 | Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. |
| Q77318398 | Hereditary hemorrhagic telangiectasia |
| Q90601595 | Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: clinical aspects |
| Q45245802 | Hereditary hemorrhagic telangiectasia in Japanese patients |
| Q51647298 | Hereditary hemorrhagic telangiectasia with multiple hepatic and pulmonary nodular lesions. |
| Q36440899 | Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway |
| Q33854081 | Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement |
| Q42166170 | Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. |
| Q35842042 | Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians |
| Q36480144 | Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures |
| Q46744808 | Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients |
| Q35012638 | Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. |
| Q43947391 | Hereditary intraosseous vascular malformation of the craniofacial region: an apparently novel disorder. |
| Q46801611 | Hereditary systemic angiopathy (HSA) with cerebral calcifications, retinopathy, progressive nephropathy, and hepatopathy |
| Q33915567 | Heritable forms of pulmonary arterial hypertension |
| Q34555915 | Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet |
| Q35668755 | High temperature requirement factor A1 (HTRA1) gene regulates angiogenesis through transforming growth factor-β family member growth differentiation factor 6. |
| Q37635681 | High-Output Heart Failure Contributing to Recurrent Epistaxis Kiesselbach Area Syndrome in a Patient With Hereditary Hemorrhagic Telangiectasia |
| Q24798737 | Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer |
| Q90025662 | Homeobox B9 integrates bone morphogenic protein 4 with inflammation at atheroprone sites |
| Q34129277 | Hormonal therapy for gastrointestinal angiodysplasia |
| Q33787209 | How to improve specific databases for clinical data in rare diseases? The example of hereditary haemorrhagic telangiectasia. |
| Q48109054 | Human endoglin as a potential new partner involved in platelet-endothelium interactions |
| Q24324369 | Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1 |
| Q34387030 | Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells |
| Q28575076 | Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling |
| Q38982711 | Identification of endoglin-dependent BMP-2-induced genes in the murine periodontal ligament cell line PDL-L2. |
| Q35458472 | Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction |
| Q73594909 | Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin |
| Q54116529 | Immunodetection and characterisation of soluble CD105-TGFbeta complexes. |
| Q42210411 | Immunohistochemical analysis of a merkeloma observed in a patient affected by hereditary haemorrhagic telangiectasia |
| Q46316673 | Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia |
| Q89077897 | Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis |
| Q90362319 | Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic Telangiectasia |
| Q33999700 | Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis. |
| Q37625733 | Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia |
| Q54304957 | Increase of circulating endothelial cells in patients with Hereditary Hemorrhagic Telangiectasia. |
| Q24619354 | Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients |
| Q42527108 | Inducible and selective transgene expression in murine vascular endothelium |
| Q37520379 | Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma. |
| Q35079425 | Insights into the genetic and molecular basis of primary pulmonary hypertension. |
| Q39648406 | Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice |
| Q27308141 | Integrity of Narrow Epithelial Tubes in the C. elegans Excretory System Requires a Transient Luminal Matrix |
| Q24294521 | Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex |
| Q30498969 | Interaction between alk1 and blood flow in the development of arteriovenous malformations |
| Q40439079 | Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report. |
| Q83105579 | Interventional embolization of a giant pulmonary arteriovenous malformation with right-left-shunt associated with hereditary hemorrhagic telangiectasia |
| Q40436147 | Intracisternal administration of transforming growth factor-beta evokes fever through the induction of cyclooxygenase-2 in brain endothelial cells |
| Q30981889 | Intracranial arteriovenous malformations: review of epidemiologic and genetic data |
| Q40531381 | Investigation of TGFβ1-Induced Long Noncoding RNAs in Endothelial Cells |
| Q33981941 | Investigation of endoglin wild-type and missense mutant protein heterodimerisation using fluorescence microscopy based IF, BiFC and FRET analyses |
| Q35106314 | Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets |
| Q57735460 | Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation |
| Q30278788 | Lacritin and other autophagy associated proteins in ocular surface health |
| Q57137366 | Locus for susceptibility for familial capillary malformation (‘port-wine stain’) maps to 5q |
| Q37904773 | Loeys-Dietz syndrome: cardiovascular, neuroradiological and musculoskeletal imaging findings |
| Q37949945 | Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: case report and literature review |
| Q28506951 | Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor |
| Q35922155 | Lung organogenesis |
| Q34711380 | Management of patients with hereditary hemorrhagic telangiectasia undergoing general anesthesia: a cohort from a single academic center's experience |
| Q24563592 | Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21 |
| Q52196601 | Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. |
| Q33723271 | Medical applications of transforming growth factor-beta |
| Q35969088 | Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response |
| Q24796385 | Modelling neuroinflammatory phenotypes in vivo |
| Q35114532 | Modulation of TGF-β signaling by endoglin in murine hemangioblast development and primitive hematopoiesis |
| Q55539866 | Molecular Basis of Vascular Birthmarks. |
| Q24302138 | Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia |
| Q90835381 | Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms |
| Q40836393 | Molecular diagnostics for cardiovascular disease |
| Q34375946 | Molecular genetics of vascular malformations |
| Q37771779 | Molecular mechanisms of endothelial differentiation |
| Q33957962 | Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors? |
| Q29616150 | Molecular regulation of angiogenesis and lymphangiogenesis |
| Q44801721 | Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France |
| Q41895984 | Molecular, Cellular, and Genetic Determinants of Sporadic Brain Arteriovenous Malformations |
| Q28084374 | Mononuclear cells and vascular repair in HHT |
| Q37616786 | Mouse Models of Cerebral Arteriovenous Malformation |
| Q38367817 | Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges |
| Q42012273 | Multifocal cerebral venous malformations and associated developmental venous anomalies in a case of blue rubber bleb nevus syndrome |
| Q41572523 | Multiple Coronary Artery Microfistulas in a Girl with Kleefstra Syndrome |
| Q42047155 | Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: illustration of complexity in molecular diagnostic interpretation |
| Q37374995 | Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative |
| Q36288806 | Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1. |
| Q33464720 | Mutation analysis of "Endoglin" and "Activin receptor-like kinase" genes in German patients with hereditary hemorrhagic telangiectasia and the value of rapid genotyping using an allele-specific PCR-technique |
| Q30371147 | Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia |
| Q41046801 | Mutational analysis of a transforming growth factor-beta receptor binding site |
| Q31912670 | Mutations in the ALK-1 gene and the phenotype of hereditary hemorrhagic telangiectasia in two large Danish families |
| Q34381015 | Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. |
| Q42114336 | Mutual interaction between endothelial cells and mural cells enhances BMP9 signaling in endothelial cells. |
| Q44401260 | National mutation study among Danish patients with hereditary haemorrhagic telangiectasia. |
| Q38359789 | Neural Regulation of CNS Angiogenesis During Development |
| Q36234663 | Neuroradiological Manifestations of Hereditary Hemorrhagic Telangiectasia in 139 Japanese Patients |
| Q35613217 | Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations |
| Q36246414 | Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years |
| Q38086269 | Normal and abnormal pulmonary arteriovenous shunting: occurrence and mechanisms |
| Q36381160 | Novel biochemical pathways of endoglin in vascular cell physiology. |
| Q35092843 | Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia |
| Q38031309 | Novel stem cell-based drug discovery platforms for cardiovascular disease |
| Q35072955 | Organ specific optical imaging of mitochondrial redox state in a rodent model of hereditary hemorrhagic telangiectasia-1 |
| Q33680436 | Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha |
| Q43235423 | Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells |
| Q42357211 | PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia |
| Q39852529 | Pathogenesis of Brain Arteriovenous Malformations. |
| Q34187184 | Pathogenesis of hemangioma |
| Q34540738 | Pathogenesis of vascular anomalies |
| Q64898571 | Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia. |
| Q38374758 | Pericytes as targets in hereditary hemorrhagic telangiectasia. |
| Q92421283 | Pericytes in Hereditary Hemorrhagic Telangiectasia |
| Q58067565 | Perturbations of BMP/TGF-β and VEGF/VEGFR signalling pathways in non-syndromic sporadic brain arteriovenous malformations (BAVM) |
| Q33671853 | Phytoestrogens and breast cancer |
| Q43735034 | Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases |
| Q42757117 | Platelet-derived growth factor receptors direct vascular development independent of vascular smooth muscle cell function. |
| Q35842264 | Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. |
| Q38199567 | Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases |
| Q33416340 | Pre-eclampsia part 1: current understanding of its pathophysiology |
| Q37362662 | Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection |
| Q93015590 | Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma |
| Q35143007 | Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease |
| Q40186283 | Prevalence of hereditary hemorrhagic telangiectasia in patients operated for cerebral abscess: a retrospective cohort analysis |
| Q80535500 | Primary and immortalized mouse epicardial cells undergo differentiation in response to TGFbeta |
| Q73370839 | Primary pulmonary hypertension |
| Q46751520 | Proteomic identification of activin receptor-like kinase-1 as a differentially expressed protein during hyaloid vascular system regression |
| Q34414793 | Pulmonary arterio-venous malformations in a patient with a novel mutation in exon 10 of the ACVRL1 gene |
| Q82356213 | Pulmonary arteriovenous malformation causing sudden death due to spontaneous hemothorax |
| Q50961914 | Pulmonary arteriovenous malformation in two adult alpacas (Vicugna pacos). |
| Q58554918 | Pulmonary arteriovenous malformations |
| Q38206558 | Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications |
| Q37168913 | Pulmonary arteriovenous malformations and migraine: a new vision |
| Q48024642 | Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complications. |
| Q52237999 | Pulmonary arteriovenous malformations. A state of the art review. |
| Q33957043 | Pulmonary arteriovenous malformations: a clinical review |
| Q41252993 | Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy |
| Q34967047 | Pulmonary artery endothelial cell phenotypic alterations in a large animal model of pulmonary arteriovenous malformations after the Glenn shunt |
| Q54566344 | Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress. |
| Q40874747 | Pulmonary hypertension in hereditary haemorrhagic telangiectasia |
| Q42370679 | Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability |
| Q36886900 | Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease). |
| Q44225835 | Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. |
| Q54540655 | RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations. |
| Q33799171 | RNAseq based transcriptomics study of SMCs from carotid atherosclerotic plaque: BMP2 and IDs proteins are crucial regulators of plaque stability. |
| Q34904041 | Rare manifestations in a case of Osler-Weber-Rendu disease |
| Q30491276 | Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia |
| Q90484471 | Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation: Clinical Implications and Physiopathological Insights |
| Q73468157 | Recurrent epistaxes in hereditary haemorrhagic telangiectasia |
| Q36640570 | Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure |
| Q34382591 | Reducing Jagged 1 and 2 levels prevents cerebral arteriovenous malformations in matrix Gla protein deficiency |
| Q24312839 | Regulation of ALK-1 signaling by the nuclear receptor LXRbeta |
| Q39134073 | Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules |
| Q36000743 | Regulation of TGF-β receptor hetero-oligomerization and signaling by endoglin. |
| Q35233736 | Research on potential biomarkers in hereditary hemorrhagic telangiectasia. |
| Q26821836 | Role of endoglin in fibrosis and scleroderma |
| Q38009855 | Role of high endothelial postcapillary venules and selected adhesion molecules in periodontal diseases: a review. |
| Q92734444 | Role of soluble endoglin in BMP9 signaling |
| Q34136011 | Role of transforming growth factor beta in cancer |
| Q36677493 | Role of transforming growth factor-beta in cancer progression |
| Q36927105 | SMAD4 mutations found in unselected HHT patients. |
| Q73122354 | Scleroderma: a disease related to damaged proteins? |
| Q33862377 | Screening assay for blood vessel maturation inhibitors |
| Q38885656 | Screening for arteriovenous malformations in hereditary haemorrhagic telangiectasia |
| Q48536100 | Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician |
| Q99607650 | Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia |
| Q38522096 | Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy |
| Q34143652 | Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressure |
| Q55300952 | Severe Hepatic and Pulmonary Involvement in Rendu-Osler-Weber Syndrome. |
| Q24304467 | Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3 |
| Q28303118 | Signal transduction by members of the transforming growth factor-beta superfamily |
| Q38915720 | Signaling Receptors for TGF-β Family Members |
| Q41750930 | Signaling angiogenesis and lymphangiogenesis |
| Q35133457 | Skin signs of gastrointestinal disease |
| Q36746119 | Slow-flow vascular malformations |
| Q33883990 | Small intestinal bleeding |
| Q28244053 | Soluble endoglin contributes to the pathogenesis of preeclampsia |
| Q37411686 | Soluble endoglin modulates aberrant cerebral vascular remodeling |
| Q58703191 | Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia |
| Q35314203 | Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth |
| Q55058075 | Somatic mosaicism in ACVRL1 with transmission to several offspring affected with severe pulmonary arterial hypertension. |
| Q34223309 | Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium |
| Q33537701 | Specificity in transforming growth factor-beta signaling pathways |
| Q35131973 | Spinal cord arteriovenous shunts: from imaging to management |
| Q41566148 | Splenic Involvement in Hereditary Hemorrhagic Telangiectasia |
| Q30756071 | Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation |
| Q34557333 | Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1 |
| Q34162465 | Structural and functional insights into endoglin ligand recognition and binding. |
| Q33773949 | Supermodels and disease: insights from the HHT mice. |
| Q34414642 | Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis |
| Q33804136 | TGF-beta and cancer. |
| Q41469706 | TGF-beta and the endothelium during immune injury |
| Q41659039 | TGF-beta receptor signaling |
| Q34421804 | TGF-beta signaling in cancer--a double-edged sword |
| Q37359962 | TGF-beta signaling in vascular biology and dysfunction |
| Q41709008 | TGF-beta1-binding proteins on human bone marrow stromal cells |
| Q38256407 | TGF-β & BMP receptors endoglin and ALK1: overview of their functional role and status as antiangiogenic targets. |
| Q39155183 | TGF-β Family Signaling in Connective Tissue and Skeletal Diseases |
| Q90631766 | TGF-β Signaling |
| Q87681974 | TGF-β Signaling in Control of Cardiovascular Function |
| Q37880676 | TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β. |
| Q35593959 | TGF-β signaling and its role in the regulation of hematopoietic stem cells |
| Q24299382 | TIMAP, a novel CAAX box protein regulated by TGF-beta1 and expressed in endothelial cells |
| Q47705980 | Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology. |
| Q26783734 | Targeting BMP signalling in cardiovascular disease and anaemia |
| Q36106240 | Targeting endoglin, an auxiliary transforming growth factor β coreceptor, to prevent fibrosis and heart failure |
| Q34462802 | Targeting under-diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases? |
| Q36165049 | Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension |
| Q34021937 | Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia |
| Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
| Q52953280 | The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. |
| Q36875639 | The Caenorhabditis elegans Excretory System: A Model for Tubulogenesis, Cell Fate Specification, and Plasticity |
| Q28276556 | The Discovery and Early Days of TGF-β: A Historical Perspective |
| Q99614247 | The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 |
| Q47789592 | The Lung in Hereditary Hemorrhagic Telangiectasia. |
| Q31153252 | The Prevalence of Malformations of Cortical Development in a Pediatric Hereditary Hemorrhagic Telangiectasia Population. |
| Q41669775 | The Role of Endoglin in Myocardial Fibrosis |
| Q37261631 | The TGF-beta paradox in human cancer: an update |
| Q38784881 | The TGF-β Signalling Network in Muscle Development, Adaptation and Disease. |
| Q41863950 | The Vascular Microenvironment and Systemic Sclerosis |
| Q24678806 | The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2 |
| Q38048775 | The complex regulation of TGF-β in cardiovascular disease |
| Q27027507 | The genetics of pulmonary arterial hypertension |
| Q33855377 | The molecular basis of lung morphogenesis |
| Q33537697 | The molecular basis of vascular disorders |
| Q26992278 | The molecular genetics and cellular mechanisms underlying pulmonary arterial hypertension |
| Q28088632 | The molecular regulation of arteriovenous specification and maintenance |
| Q34544980 | The pathobiology of vascular malformations: insights from human and model organism genetics |
| Q37775427 | The physiological role of endoglin in the cardiovascular system. |
| Q33222328 | The role of Smad signaling in hematopoiesis |
| Q38273688 | The role of endoglin in kidney fibrosis |
| Q38988081 | The role of genetics in pulmonary arterial hypertension |
| Q42578955 | The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase |
| Q45284478 | The use of recombinant vaccinia virus to generate monoclonal antibodies against the cell-surface glycoprotein endoglin. |
| Q48110659 | The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study |
| Q61764122 | Three novel mutations in the activin receptor-like kinase 1 (ALK-1) gene in hereditary hemorrhagic telangiectasia type 2 in Brazilian patients |
| Q38834183 | Time to make the doughnuts: Building and shaping seamless tubes |
| Q92281605 | Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition) |
| Q48070397 | Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. |
| Q41391410 | Transforming growth factor beta s and wound healing |
| Q34012586 | Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling |
| Q38085966 | Transforming growth factor β family members in regulation of vascular function: in the light of vascular conditional knockouts |
| Q34438032 | Transforming growth factor-beta signal transduction in epithelial cells. |
| Q41196594 | Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. |
| Q34814841 | Transforming growth factor-beta1 (TGF-beta1): a potential recovery signal in the post-ischemic kidney. |
| Q41489951 | Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity |
| Q35852389 | Transforming growth factor-β and smooth muscle differentiation |
| Q34789300 | Transforming growth factor-β and the hallmarks of cancer |
| Q74747006 | Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology |
| Q33284783 | Treatment of cutaneous and mucosal telangiectases in hereditary hemorrhagic telangiectasia: Report of three cases. |
| Q28592403 | Type III transforming growth factor beta receptor regulates vascular and osteoblast development during palatogenesis |
| Q51030177 | Umbilical vein and placental vessels from newborns with hereditary haemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin. |
| Q36028146 | Understanding angiogenesis: a clue for understanding vascular malformations. |
| Q35054155 | Update on the molecular genetics of vascular anomalies |
| Q43247557 | Usefulness of Multidetector 3D-CT Angiography in the Evaluation of Infantile Perimedullary Spinal Arteriovenous Fistula |
| Q35964733 | Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure |
| Q42080847 | VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2. |
| Q92537673 | Variant analysis in Chinese families with hereditary hemorrhagic telangiectasia |
| Q49711122 | Vascular Anomalies Caused by Abnormal Signaling within Endothelial Cells: Targets for Novel Therapies |
| Q54355027 | Vascular Anomalies: From a Clinicohistologic to a Genetic Framework. |
| Q57136753 | Vascular Malformations |
| Q27025402 | Vascular anomalies: from genetics toward models for therapeutic trials |
| Q37778482 | Vascular development: genetic mechanisms and links to vascular disease |
| Q37344793 | Vascular disease in scleroderma |
| Q58034430 | Vascular disorders of the liver |
| Q24310216 | Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2 |
| Q39326100 | Vascular heterogeneity and specialization in development and disease. |
| Q34197723 | Vascular malformations: localized defects in vascular morphogenesis |
| Q60035466 | Vascularisation de la tête et du cou au cours du développement |
| Q37768939 | Vasculogenesis and angiogenesis: molecular and cellular controls. Part 1: growth factors |
| Q53738385 | Vein of Galen Aneurysmal Malformation in Monozygotic Twin. |
| Q35443190 | Visceral manifestations in hereditary haemorrhagic telangiectasia type 2 |
| Q38225366 | We have contact: endothelial cell-smooth muscle cell interactions |
| Q47399778 | Whole-mount prostate sections reveal differential endoglin expression in stromal, epithelial, and endothelial cells with the development of prostate cancer |
| Q35937586 | Wiring the vascular circuitry: from growth factors to guidance cues |
| Q81688275 | Yeast-secreted recombinant extracellular domain of human CD105 antigen is able to bind TGF-beta type II receptor in vitro |
| Q79811011 | [Cerebrovascular ischemic accident secondary to Rendu-Osler-Weber disease] |
| Q81512884 | [Pulmonary vascular manifestations in hereditary hemorrhagic telangiectasia] |
| Q77475129 | [Rendu-Osler-Weber disease. Descriptive study of 17 cases] |
| Q80145941 | [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid] |
| Q83365369 | [Unclear peranal blood loss in a 21-year-old man] |
| Q37260433 | beta8 integrins are required for vascular morphogenesis in mouse embryos |
| Q40540639 | cAMP inhibits TGFbeta1-induced in vitro angiogenesis. |
| Q35917632 | miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling |
Search more.